Renal vascular and biochemical responses to systemic renin inhibition in dogs at low renal perfusion pressure

Journal of Cardiovascular Pharmacology

Volumn 34, Issue 5, 1999, Pages 674-682

  Clozel, Jean Paul ^a,b   Véniant, Murielle M ^a,c   Qiu, Changbin ^a   Sprecher, Urs ^a   Wolfgang, Robert ^a   Fischli, Walter ^a,b  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b ACTELION PHARMACEUTICALS LTD   (Switzerland)

^c GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

Author keywords

Dog; Hypertension; Kidney; Renal blood flow; Renin inhibitor; Renin angiotensin system

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN I; CIPROKIREN; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; DRUG EFFECT; HORMONE ACTION; HORMONE INHIBITION; HORMONE SYNTHESIS; KIDNEY BLOOD FLOW; KIDNEY PERFUSION; KIDNEY VASCULAR RESISTANCE; MALE; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; DOGS; HEART RATE; IMIDAZOLES; KIDNEY; MALE; PERFUSION; RENAL CIRCULATION; RENIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 0032742063     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199911000-00008     Document Type: Article

References (46)

1. Seikaly MG, Arant BS Jr, Seney FD Jr. Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J Clin Invest 1990;86:1352-7.
2. Siragy HM, Howell NL, Peach MJ, Carey RM. Combined intrarenal blockade of the renin-angiotensin system in the conscious dog. Am J Physiol 1990;258:F522-9.
3. Levens NR, Peach MJ, Carey RM. Role of the intrarenal renin-angiotensin system in the control of renal function. Circ Res 1981; 48:157-67.
4. Hall JE. Regulation of glomerular filtration rate and sodium excretion by angiotensin II. Fed Proc 1986;45:1431-7.
5. Harris RC, Cheng H-F. The intrarenal renin-angiotensin system: a paracrine system for the local control of renal function separate from the systemic axis. Exp Nephrol 1996;4(suppl 1):2-7.
6. Campbell D, Habener J. Angiotensinogen gene is expressed and differentially regulated in multiple tissue of the rat. J Clin Invest 1986;78:31-9.
7. Celio MR, Inagami T. Angiotensin II immunoreactivity coexists with renin in the juxtaglomerular granular cells of the kidney. Proc Natl Acad Sci U S A 1981;78:3897-900.
8. Navar LG, Rosivall L, Carmines PK, Oparil S. Effects of locally formed angiotensin II on renal hemodynamics. Fed Proc 1986;45: 4148-53.
9. Gomez RA, Lynch KR, Chevalier RL, et al. Renin and angiotensinogen gene expression in the maturing rat kidney. Am J Physiol 1988;254:F582-7.
10. Morgan T, Davis JM. Renin secretion at the individual nephron level. Pflugers Arch 1975;359:23-31.
11. Celio MR, Inagami T. Renin in the human kidney. Histochemistry 1981;72:1-10.
12. Ingelfinger JR, Zuo WM, Fon EA, Ellison KE, Dzau VJ. In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. J Clin Invest 1990;85:417-23.
13. Ohkubo H, Nakayawa K, Tanolsa T, Nakanishi S. Tissue distribution of rat angiotensinogen mRNA and structural analysis of its heterogeneity. J Biol Chem 1986;261:319-23.
14. Blaine EH, Davis JO. Evidence for a renal vascular mechanism in renin release: new observations with graded stimulation by aortic constriction. Circ Res 1971;28(suppl 2):118-25.
15. Rosivall L, Rinder DF, Champion J, Khosla MC, Navar LG, Oparil S. Intrarenal angiotensin I conversion at normal and reduced renal blood flow in the dog. Am J Physiol 1983;245:F408-15.
16. Admiraal PJJ, Derkx FHM, Jan Danser AH, Pieterman H, Schalekamp MADH. Intrarenal de novo production of angiotensin I in subjects with renal artery stenosis. Hypertension 1990;16:555-63.
17. Schulz W, Hagler H, Buja LM, Erdos E. Ultrastructural localization of angiotensin I-converting enzyme (EC3.4.15.1) and neutral metalloendopeptidase (EC3.4.24.11) in the proximal tubule of human kidney. Lab Invest 1988;59:789-97.
18. Prunval P, Hinglais N, Alhence-Gelas F, et al. Angiotensin I converting enzyme in human intestine and kidney: ultrastructural immunohistochemical localization. Histochemistry 1986;85:73-80.
19. Schunkert H, Tang SS S, Litwin E, et al. Regulation of intrarenal and circulating renin-angiotensin systems in severe heart failure in the rat. Circ Res 1993;27:731-5.
20. Semple PF, A. Cumming MM, Millar JA. Angiotensins I and II in renal vein blood. Kidney Int 1979;15:276-82.
21. Bailie MD, Rector FC Jr, Seldin DW. Angiotensin II in arterial and renal venous plasma and renal lymph in the dog. J Clin Invest 1971;50:119-26.
22. Meyer TW, Anderson S, Rennke HG, Brenner BM. Reversing glomerular hypertension stabilized established glomerular injury. Kidney Int 1987;31:752-9.
23. Anderson S, Rennke HG, Garcia DL, Brenner BM. Short- and long-term effects of antihypertensive therapy in the diabetic rat. Kidney Int 1989;36:526-36.
24. Anderson S, Diamond JR, Karnovsky MJ, Brenner BM. Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in rat model of nephrotic syndrome. J Clin Invest 1988;82:1757-68.
25. Remuzzi A, Puntorieri S, Battaglia C, Bertani T, Remuzzi G. Angiotensin-converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat. J Clin Invest 1990;85:541-9.
26. Simons JL, Provoost AP, Anderson S, Rennke HG, Troy JL, Brenner BM. Modulation of glomerular hypertension defines susceptibility to progressive glomerular injury. Kidney Int 1994;46:396-404.
27. El Amrani A-IK, Menard J, Gonzales MF, Michel J-B. Effects of blocking the angiotensin II receptor, converting enzyme, renin activity on the renal hemodynamics of normotensive guinea pigs. J Cardiovasc Pharmacol 1993;22:231-9.
28. Neisius D, Wood JM, Hobauer KG. Renal vasodilation after inhibition of renin or converting enzyme in marmoset. Am J Physiol 1986;251:H897-902.
29. Siragy HM, Lamb NE, Rose CE Jr, Peach MJ, Carey RM. Intrarenal renin inhibition increases renal function by an angiotensin II-dependent mechanism. Am J Physiol 1988;255:F749-54.
30. Verburg KM, Kleinen HD, Chekal MA, Kadam JRC, Young GA. Renal hemodynamic and excretory responses to renin inhibition induced by A-64662. J Pharmacol Exp Ther 1989;252:449-55.
31. Verburg KM, Young GA, Rosenberg SH, Kleinert HD. Effect of intrarenal renin inhibition on renal hemodynamics and excretory function. Am J Physiol 1990;259:R7-14.
32. Hollenberg NK, Fisher NDL. Renal circulation and blockade of the renin-angiotensin system: is angiotensin-converting enzyme inhibition the last word? Hypertension 1995;26:602-9.
33. Cordero P, Fisher NDL, Moor TJ, Gleason R, Williams GH, Hollenberg NK. Renal and endocrine responses to renin inhibitor, enakiren, in normal humans. Hypertension 1991;17:510-6.
34. Fisher NDL, Allen D, Kifor I, et al. Responses to converting enzyme and renin inhibition: role of angiotensin II in humans. Hypertension 1994;23:44-51.
35. Wood JM, Schnell CR, Levens NR. Kidney is an important target for the antihypertensive action of an angiotensin II receptor antagonist in spontaneously hypertensive rats. Hypertension 1993; 21:1056-61.
36. Fischli W, Clozel J-P, Breu V, et al. Ciprokiren (Ro 44-9375) a renin inhibitor with increasing effects on chronic treatment. Hypertension 1994;24:163-9.
37. Fischli W, Clozel J-P, Amrani KE, et al. Ro 42-5892 is a potent orally active renin inhibitor in primates. Hypertension 1991;18:22-31.
38. Sannajust F, Cerutti C, Koenig-Berard E, Sassard J. Influence of anesthesia on the cardiovascular effects of rilmenidine and clonidine in spontaneously hypertensive rats. Br J Pharmacol 1992; 105:542-8.
39. Knoblich PR, Freeman RH, Villarreal D. Pressure-dependent renin release during chronic blockade of nitric oxide synthase. Hypertension 1996;284:738-42.
40. Braam B, Mitchell KD, Fox J, Navar LG. Proximal tubular secretion of angiotensin II in the rats. Am J Physiol 1993;264:F891-8.
41. Ikemoto F, Song G, Tominaga M, Kanayama Y, Yamamoto K. Angiotensin converting enzyme predominates in the inner cortex and medulla of the rat kidney. Biochem Biophys Res Commun 1987;144:915-21.
42. Zou LX, Imig JD, von Thun AM, Hymel, One H, Navar LG. Receptor-mediated intrarenal angiotensin II augmentation in angiotensin II-infused rats. Hypertension 1996;28:669-77.
43. Ng KKF, Vane JR. Fate of angiotensin I in the circulation. Nature 1968;218:144-50.
44. Britton SL. Intrarenal vascular effects of angiotensin I and angiotensin II. Am J Physiol 1981;240:H914-9.
45. Misumi J, Gardes J, Gonzalez MF, Corvol P, Menard J. Angiotensinogen's role in ANG formation, renin release, and renal hemodynamics in isolated perfused kidney. Am J Physiol 1989;256: F719-27.
46. Szidon P, Bairey N, Oparil S. Effect of acute hypoxia on pulmonary conversion of angiotensin I to angiotensin II in dogs. Circ Res 1980;46:221-6.